.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Updates in the Management of Mantle Cell Lymphoma

EP. 1: Updates in Management of Mantle Cell Lymphoma

January 30th 2020

EP. 2: Selecting a BTK Inhibitor for Mantle Cell Lymphoma

January 30th 2020

EP. 3: BTK Inhibitors in MCL: AEs, Specificity, and Interactions

January 30th 2020

EP. 4: Mantle Cell Lymphoma: Chemotherapy-Free Treatment Options

January 30th 2020

EP. 5: CAR T-Cell Therapy and the Future Management of MCL

January 30th 2020

EP. 6: MCL: FDA Approval of a Second-Generation BTK Inhibitor

January 30th 2020

EP. 7: Priority Review in RET Fusion+ NSCLC and Thyroid Cancers, Breakthrough Status in MDS, and More

January 30th 2020